At OZ Biosciences, we believe that true innovation in molecular delivery and cell engineering happens through partnerships.
With over 20 years of expertise in polymers, lipid-based technologies, transfection reagents, mRNA and LNPs, we work hand-in-hand with partners to transform breakthrough ideas into real-world solutions — from research to clinical applications.
“Let’s create partnerships today that drive innovation and business growth for the future.” CEO, Olivier ZELPHATI
Our Partnership Opportunities
We are open to a wide range of collaborations, including:
Strategic Alliance
- Long-term, multi-project collaborations with pharma, biotech, or CDMOs.
- Can include joint investment, preferred supplier agreements, or first-rights of negotiation.
- Designed to build enduring partnerships.
Licensing
- Out-Licensing: granting rights for the commercial use of OZB’s proprietary technologies, enabling partners to accelerate their development with validated, high-quality solutions.
- In-Licensing: we actively seek to integrate external innovations into our portfolio when they strengthen our expertise, broaden our applications, or create new growth opportunities.
OEM & White Label
- OEM Supply: Seamless integration of OZB’s trusted technologies into your own solutions or kits — with the assurance of consistent quality and reliability.
- White Label: Leverage OZB’s expertise while marketing our products under your own brand, expanding your portfolio without the burden of development.
Co-development & Evaluation
- Joint Development: Collaborate with OZB to co-develop innovative technologies and solutions, leveraging our expertise from research tools to translational applications.
- Early Evaluation: Gain early access to OZB’s proprietary platforms to explore novel applications, validate concepts, and unlock new opportunities.
Distribution
- Distribution agreements to expand our global reach and provide local support to researchers worldwide.
Grants & Collaborative Programs
- Participation in EU and internationally funded projects, bringing OZB expertise in delivery, cell & gene therapy, and vaccine development to ambitious consortia. Check our grants projects.
Why Partner with OZ Biosciences?
Cutting-Edge Proprietary Technologies
We own and develop a broad portfolio of proprietary products, including our LNPs, Lentiblast® Premium, and a wide range of catalog reagents, enabling innovation from research to clinical translation.
20+ Years of Experience
A solid track record in scientific innovation, product development, and manufacturing of high-quality reagents.
Proven Collaboration History
Trusted partner of academic institutions, biotech innovators, and global pharma companies.
Agile & Scalable SME
Flexibility to adapt to your needs, with the ability to customize, scale, and accelerate projects efficiently.
Global Reach, Local Support
Established worldwide distribution network ensuring reliability, quality, and consistent supply.
Let's Collaborate
We are always open to exploring new synergies with innovative partners worldwide.
CIR AGREEMENT
|
Oz Biosciences has obtained the Crédit d’Impôt Recherche (CIR) Agreement by the French Ministry of Higher Education, Research, and Innovation. This official accreditation enables French companies looking to collaborate with us on a biology R&D project (drug delivery, mRNAs, LNPs,...) to benefit from this accreditation and receive tax advantages. Contact us to explore how we can collaborate on your next R&D project! |
|
